These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10360595)

  • 1. Foscarnet-induced crystalline glomerulonephritis with nephrotic syndrome and acute renal failure after kidney transplantation.
    Zanetta G; Maurice-Estepa L; Mousson C; Justrabo E; Daudon M; Rifle G; Tanter Y
    Transplantation; 1999 May; 67(10):1376-8. PubMed ID: 10360595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irreversible glomerular lesions induced by crystal precipitation in a renal transplant after foscarnet therapy for cytomegalovirus infection.
    Justrabo E; Zanetta G; Martin L; Assem M; Mousson C; Maurice-Estepa L; Rifle G; Tanter Y
    Histopathology; 1999 Apr; 34(4):365-9. PubMed ID: 10231404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular and tubulointerstitial foscarnet nephropathy of kidney allograft with emphasis on ultrastructural findings: A case report.
    Pleško J; Kovač D; Arsov Z; Lindič J; Škoberne A; Ferluga D; Kojc N
    Clin Nephrol; 2021 Suppl; 96(1):127-132. PubMed ID: 34643504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular foscarnet crystal precipitation causing multiorgan failure.
    Philipponnet C; Michel PA; Daudon M; Brocheriou I; Boffa JJ
    Am J Kidney Dis; 2015 Jan; 65(1):152-5. PubMed ID: 25301103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of crystals in kidneys of AIDS patients treated with foscarnet.
    Maurice-Estepa L; Daudon M; Katlama C; Jouanneau C; Sazdovitch V; Lacour B; Beaufils H
    Am J Kidney Dis; 1998 Sep; 32(3):392-400. PubMed ID: 9740154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report.
    Iwami D; Ogawa Y; Fujita H; Morita K; Sasaki H; Oishi Y; Higuchi H; Hatanaka K; Shinohara N
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():63-6. PubMed ID: 26970406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crescentic glomerulonephritis and crystals within glomerular capillaries in an AIDS patient treated with foscarnet.
    Trolliet P; Dijoud F; Cotte L; Cahen R; François B; Trepo C; Patricot LM
    Am J Nephrol; 1995; 15(3):256-9. PubMed ID: 7618652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus-induced tubulointerstitial nephritis in a renal allograft treated by foscarnet therapy.
    Wong KM; Chan YH; Chan SK; Mak CK; Chau KF; Li CS
    Am J Nephrol; 2000; 20(3):222-4. PubMed ID: 10878406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute kidney injury in a renal transplant recipient due to concomitant use of vancomycin and foscarnet.
    Kwan LP; Mok MM; Choy BY; Chan TM
    Nephrology (Carlton); 2017 Oct; 22(10):821-822. PubMed ID: 28921753
    [No Abstract]   [Full Text] [Related]  

  • 10. Tubulointerstitial nephritis caused by the antiviral agent foscarnet.
    Nyberg G; Svalander C; Blohmé I; Persson H
    Transpl Int; 1989 Dec; 2(4):223-7. PubMed ID: 2560634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible acute renal failure caused by the combined use of foscarnet and cyclosporin in organ transplanted patients.
    Morales JM; Muñoz MA; Fernández Zataraín G; García Cantón C; García Rubiales MA; Andrés A; Aguado JM; Gonzalez Pinto I
    Nephrol Dial Transplant; 1995; 10(6):882-3. PubMed ID: 7566623
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring.
    MacGregor RR; Graziani AL; Weiss R; Grunwald JE; Gambertoglio JG
    J Infect Dis; 1991 Oct; 164(4):785-7. PubMed ID: 1654363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal precipitation and granulomatous inflammation in multiple organs after foscarnet therapy in a lung transplant recipient.
    Tischler V; Schuurmans MM; Boehler A; Gaspert A
    J Heart Lung Transplant; 2012 Sep; 31(9):1037-40. PubMed ID: 22766024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrotoxicity of antiviral therapies.
    Becker BN; Schulman G
    Curr Opin Nephrol Hypertens; 1996 Jul; 5(4):375-9. PubMed ID: 8823538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients.
    Mattes FM; Hainsworth EG; Geretti AM; Nebbia G; Prentice G; Potter M; Burroughs AK; Sweny P; Hassan-Walker AF; Okwuadi S; Sabin C; Amooty G; Brown VS; Grace SC; Emery VC; Griffiths PD
    J Infect Dis; 2004 Apr; 189(8):1355-61. PubMed ID: 15073671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brincidofovir Use after Foscarnet Crystal Nephropathy in a Kidney Transplant Recipient with Multiresistant Cytomegalovirus Infection.
    Vial R; Zandotti C; Alain S; Decourt A; Jourde-Chiche N; Purgus R; Bornet C; Daniel L; Moal V; Legris T
    Case Rep Transplant; 2017; 2017():3624146. PubMed ID: 28348914
    [No Abstract]   [Full Text] [Related]  

  • 17. Foscarnet-induced hypercalcaemia in AIDS.
    Gayet S; Ville E; Durand JM; Mars ME; Morange S; Kaplanski G; Gallais H; Soubeyrand J
    AIDS; 1997 Jul; 11(8):1068-70. PubMed ID: 9223751
    [No Abstract]   [Full Text] [Related]  

  • 18. Foscarnet-induced electrolyte abnormalities in a bone marrow transplant patient receiving parenteral nutrition.
    Matarese LE; Speerhas R; Seidner DL; Steiger E
    JPEN J Parenter Enteral Nutr; 2000; 24(3):170-3. PubMed ID: 10850943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Removal of Foscarnet by hemodialysis using dialysate-side values.
    Sam R; Patel SB; Popli A; Leehey DJ; Gambertoglio JG; Ing TS
    Int J Artif Organs; 2000 Mar; 23(3):165-7. PubMed ID: 10795660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT): a randomised study.
    Moretti S; Zikos P; Van Lint MT; Tedone E; Occhini D; Gualandi F; Lamparelli T; Mordini N; Berisso G; Bregante S; Bruno B; Bacigalupo A
    Bone Marrow Transplant; 1998 Jul; 22(2):175-80. PubMed ID: 9707026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.